Pricing Log in Create free account
Reset Show charts
Revenue

Your own ranges are part of Powerpack. Powerpack

Gross Profit

Your own ranges are part of Powerpack. Powerpack

Operating Income

Your own ranges are part of Powerpack. Powerpack

Net Income

Your own ranges are part of Powerpack. Powerpack

EBITDA

Your own ranges are part of Powerpack. Powerpack

EBIT

Your own ranges are part of Powerpack. Powerpack

EPS (Diluted)

Your own ranges are part of Powerpack. Powerpack

Free Cash Flow

Your own ranges are part of Powerpack. Powerpack

Operating Cash Flow

Your own ranges are part of Powerpack. Powerpack

Total Assets

Your own ranges are part of Powerpack. Powerpack

Shareholders Equity (Total)

Your own ranges are part of Powerpack. Powerpack

Total Debt

Your own ranges are part of Powerpack. Powerpack

Book value per Share

Your own ranges are part of Powerpack. Powerpack

Cash & Short Term Investments

Your own ranges are part of Powerpack. Powerpack

TTM trailing twelve months Q latest quarter A latest fiscal year D daily, from the latest close

Showing the 10 largest of 1101 matches.
1 filter active
Table Snapshots

  1. Eli Lilly and Company

    LLY Healthcare · Drug Manufacturers General · US

    $1,366.60 +45.8% 1Y
    Low $850.51 High $1,453.00

    Eli Lilly discovers, develops, manufactures and markets medicines for people. Founded in 1875 and headquartered in Indianapolis, it is led by Chair, President and Chief Executive Officer David Ricks.

    Market cap $1.28T
    Revenue growth (Q) +38.6%
    EPS growth (Q) +16.3%
    FCF growth (Q) +21.8%
    Revenue growth (next yr) +40.9%
    Net margin 31.9%
    ROE 86.0%
    P/E 44.3×
    Forward P/E 39.6×
    P/FCF 55.8×
    Dividend yield 0.49%
    Insider ownership 4.94%
    Insider buys / sells (12M) — $310.3M
    Reported FY2022 FY2023 FY2024 FY2025 TTM
    Revenue $28.5B $34.1B $45.0B $65.2B $86.5B
    EPS $6.90 $5.80 $11.71 $22.95 $30.81
    Free cash flow $5.7B $792.0M $3.8B $9.0B $19.7B
    Net debt $12.5B $15.4B $25.3B $33.6B $42.1B

  2. Johnson & Johnson

    JNJ Healthcare · Drug Manufacturers General · US

    $275.25 +47.2% 1Y
    Low $185.12 High $282.02

    Johnson & Johnson is a healthcare company that researches, develops, manufactures and sells prescription medicines and medical technologies. It is a holding company whose operating companies manage day-to-day operations in markets around the world.

    Market cap $655.6B
    Revenue growth (Q) +5.86%
    EPS growth (Q) −95.8%
    FCF growth (Q) −21.4%
    Revenue growth (next yr) +7.46%
    Net margin 16.2%
    ROE 20.0%
    P/E 41.7×
    Forward P/E 40.4×
    P/FCF 31.6×
    Dividend yield 1.92%
    Insider ownership 0.40%
    Insider buys / sells (12M) $0.3M $150.7M
    Reported FY2022 FY2023 FY2024 FY2025 TTM
    Revenue $80.0B $85.2B $88.8B $94.2B $99.3B
    EPS $6.73 $13.72 $5.79 $11.03 $6.60
    Free cash flow $17.7B $18.6B $20.5B $20.4B $21.0B
    Net debt $4.6B $3.0B $6.1B $19.3B $18.6B

  3. AbbVie Inc.

    ABBV Healthcare · Drug Manufacturers General · US

    $290.81 +32.8% 1Y
    Low $190.75 High $302.93

    AbbVie is a research-based biopharmaceutical company that develops, manufactures and sells medicines and therapies around the world. It was founded in 2012, is headquartered in North Chicago and is led by Chief Executive Officer Robert A. Michael.

    Market cap $509.5B
    Revenue growth (Q) +10.3%
    EPS growth (Q) +2,270.0%
    FCF growth (Q) +9.97%
    Revenue growth (next yr) +10.9%
    Net margin 15.6%
    ROE −288.7%
    P/E 50.1×
    Forward P/E 37.5×
    P/FCF 27.3×
    Dividend yield 2.38%
    Insider ownership 0.00%
    Insider buys / sells (12M) — $18.9M
    Reported FY2022 FY2023 FY2024 FY2025 TTM
    Revenue $58.1B $54.3B $56.3B $61.2B $66.0B
    EPS $6.63 $2.72 $2.39 $2.36 $5.81
    Free cash flow $24.2B $22.1B $17.8B $17.8B $18.9B
    Net debt $54.0B $46.6B $61.6B $62.2B $70.1B

  4. Merck & Co., Inc.

    MRK Healthcare · Drug Manufacturers General · US

    $146.65 +71.0% 1Y
    Low $85.80 High $156.92

    Merck & Co. is a global health care company that sells prescription medicines, vaccines and animal health products. Founded in 1891, it is headquartered in Rahway and led by Chairman, President and Chief Executive Officer Robert M. Davis.

    Market cap $362.5B
    Revenue growth (Q) +4.68%
    EPS growth (Q) −12.1%
    FCF growth (Q) +77.0%
    Revenue growth (next yr) +3.43%
    Net margin 3.64%
    ROE 5.07%
    P/E 151×
    Forward P/E 97.2×
    P/FCF 24.5×
    Dividend yield 2.32%
    Insider ownership 0.32%
    Insider buys / sells (12M) — $71.3M
    Reported FY2022 FY2023 FY2024 FY2025 TTM
    Revenue $59.3B $60.1B $64.2B $65.0B $67.4B
    EPS $5.71 $0.14 $6.74 $7.28 $0.97
    Free cash flow $14.7B $9.1B $18.1B $12.4B $14.7B
    Net debt $15.6B $26.6B $20.8B $32.2B $40.0B

  5. UnitedHealth Group Incorporated

    UNH Healthcare · Healthcare Plans · US

    $393.91 +22.5% 1Y
    Low $255.97 High $461.62

    UnitedHealth Group is a health care and well-being company built around two complementary businesses: UnitedHealthcare and Optum. UnitedHealthcare sells health benefits that help employers, individuals, seniors and people enrolled in public programs pay for and access care.

    Market cap $354.6B
    Revenue growth (Q) −0.41%
    EPS growth (Q) +76.1%
    FCF growth (Q) −15.7%
    Revenue growth (next yr) +0.34%
    Net margin 3.53%
    ROE 15.4%
    P/E 22.5×
    Forward P/E 20.4×
    P/FCF 15.5×
    Dividend yield 2.30%
    Insider ownership 0.17%
    Insider buys / sells (12M) — $0.9M
    Reported FY2022 FY2023 FY2024 FY2025 TTM
    Revenue $324.2B $371.6B $400.3B $447.6B $449.7B
    EPS $21.18 $23.86 $15.51 $13.23 $17.51
    Free cash flow $23.4B $25.7B $20.7B $16.1B $22.8B
    Net debt $26.6B $28.6B $43.2B $44.2B $40.2B